Keywords
Anesthesiology Case Reports
Cardiology Case Reports
Dentistry Case Reports
Diabetology Case Reports
Gastroenterology Case Reports
Otolaryngology Case Reports
Authors:
Shaghayegh Habibi , Tien-Chan Hsieh , Shrinkhala Khanna
1Department of Internal Medicine, Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA ,
Correspondence to Author: Shaghayegh Habibi
Abstract:
Background : An extremely dangerous side effect of heparin
that might result in a prothrombotic state is heparin-induced
thrombocytopenia (HIT). In the case of HIT, prompt heparin
withdrawal and non-heparin anticoagulant initiation are
the recommended courses of action. Still, there may be
difficulties with the treatment, especially in patients who are
resistive to HIT, have contraindications to anticoagulation,
or need immediate surgery. Furthermore, there are rare
instances in which standard anticoagulation medication fails
to provide the desired results, requiring the use of alternative
therapies including intravenous immunoglobulin (IVIG) and
plasma exchange (PLEX).
Case Report : Following liver transplant surgery, a 57-yearold male patient experienced mild acute cellular rejection,
refractory HIT, and disseminated intravascular coagulation.
Heparin was discontinued, and argatroban was started as a
thromboembolism treatment; nonetheless, transplant failure
resulted from hepatic artery thrombosis that happened in
the context of refractory HIT. One month following the initial
procedure, the patient had a second liver transplant. He
had one IVIG dose prior to the operation and one during it,
along with two PLEX sessions. The refractory HIT continued
even after receiving extensive therapy with PLEX and IVIG.
Even with catheter-directed intra-arterial thrombolysis and
argatroban treatment, hepatic artery thrombosis returned in
two weeks, and the transplant failed once more.
Conclusions : Refractory HIT has recently been treated with
perioperative PLEX and IVIG on a few occasions. This therapy
strategy was used on the first known case of a liver transplant
patient with resistant HIT. Particularly in liver transplant
recipients with HIT, more research is necessary to ascertain
the effectiveness and safety of PLEX and IVIG therapy both
before and after surgery
Keywords:
Liver Transplantation • Plasma Exchange • Thrombocytopenia • Immunoglobulins, Intravenous • Heparin
Citation:
Shaghayegh Habibi. Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient: Intravenous Immunoglobulin Use and Perioperative Plasma Exchang.. Clinical Imaging and Case Reports 2023.
Journal Info
- Journal Name: Clinical Imaging and Case Reports
- Impact Factor: 2.709**
- ISSN: 2770-9205
- DOI: 10.52338/cicaserep
- Short Name: CICASEREP
- Acceptance rate: 55%
- Volume: 6 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
INDEXING
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility